180 related articles for article (PubMed ID: 22350755)
1. BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases.
Sarszegi Z; Bognar E; Gaszner B; Kónyi A; Gallyas F; Sumegi B; Berente Z
Mol Cell Biochem; 2012 Jun; 365(1-2):129-37. PubMed ID: 22350755
[TBL] [Abstract][Full Text] [Related]
2. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
3. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
4. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
Biswas SK; Zhao Y; Sandirasegarane L
Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
[TBL] [Abstract][Full Text] [Related]
5. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway.
Ghosh J; Das J; Manna P; Sil PC
Toxicol Appl Pharmacol; 2009 Oct; 240(1):73-87. PubMed ID: 19616567
[TBL] [Abstract][Full Text] [Related]
6. Remifentanil preconditioning confers cardioprotection via c-Jun NH
Jin SY; Huang J; Zhu HJ; Wu H; Xu SJ; Irwin MG; He SF; Zhang Y
Eur J Pharmacol; 2018 Jun; 828():1-8. PubMed ID: 29559303
[TBL] [Abstract][Full Text] [Related]
7. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
8. Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.
Kovacs K; Hanto K; Bognar Z; Tapodi A; Bognar E; Kiss GN; Szabo A; Rappai G; Kiss T; Sumegi B; Gallyas F
Mol Cell Biochem; 2009 Jan; 321(1-2):155-64. PubMed ID: 18975057
[TBL] [Abstract][Full Text] [Related]
9. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes.
Engelbrecht AM; Niesler C; Page C; Lochner A
Basic Res Cardiol; 2004 Sep; 99(5):338-50. PubMed ID: 15309413
[TBL] [Abstract][Full Text] [Related]
10. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
11. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
13. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
[TBL] [Abstract][Full Text] [Related]
14. Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases.
Mester L; Szabo A; Atlasz T; Szabadfi K; Reglodi D; Kiss P; Racz B; Tamas A; Gallyas F; Sumegi B; Hocsak E; Gabriel R; Kovacs K
Neurotox Res; 2009 Jul; 16(1):68-76. PubMed ID: 19526300
[TBL] [Abstract][Full Text] [Related]
15. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats.
Kim SJ; Li M; Jeong CW; Bae HB; Kwak SH; Lee SH; Lee HJ; Heo BH; Yook KB; Yoo KY
Arch Pharm Res; 2014 Aug; 37(8):1079-85. PubMed ID: 24307060
[TBL] [Abstract][Full Text] [Related]
17. Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells.
Parmar S; Katsoulidis E; Verma A; Li Y; Sassano A; Lal L; Majchrzak B; Ravandi F; Tallman MS; Fish EN; Platanias LC
J Biol Chem; 2004 Jun; 279(24):25345-52. PubMed ID: 15056660
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms.
Dai Y; Rahmani M; Pei XY; Dent P; Grant S
Blood; 2004 Jul; 104(2):509-18. PubMed ID: 15039284
[TBL] [Abstract][Full Text] [Related]
19. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
[TBL] [Abstract][Full Text] [Related]
20. p38-MAPK and PKB/Akt, possible role players in red palm oil-induced protection of the isolated perfused rat heart?
Engelbrecht AM; Esterhuyse J; du Toit EF; Lochner A; van Rooyen J
J Nutr Biochem; 2006 Apr; 17(4):265-71. PubMed ID: 16229999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
